Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.26% | 10.23% | 14.92% | 12.16% | 10.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.26% | 10.23% | 14.92% | 12.16% | 10.39% |
| Cost of Revenue | 2.83% | 7.95% | 15.13% | 10.78% | 7.72% |
| Gross Profit | 18.62% | 11.92% | 14.77% | 13.49% | 12.83% |
| SG&A Expenses | 11.97% | 12.25% | 11.73% | 12.59% | 8.67% |
| Depreciation & Amortization | 2.86% | 2.21% | 7.81% | 6.92% | 5.26% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.40% | 8.13% | 12.13% | 11.13% | 7.25% |
| Operating Income | 211.11% | 38.82% | 39.67% | 85.71% | 640.00% |
| Income Before Tax | 148.00% | 124.00% | 45.00% | -407.84% | -108.94% |
| Income Tax Expenses | 137.50% | -85.71% | 528.57% | 139.53% | -108.21% |
| Earnings from Continuing Operations | 152.94% | 390.91% | -14.93% | -3,350.00% | -109.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 152.94% | 390.91% | -14.93% | -3,350.00% | -109.34% |
| EBIT | 211.11% | 38.82% | 39.67% | 85.71% | 640.00% |
| EBITDA | 30.77% | 15.04% | 22.71% | 15.48% | 25.81% |
| EPS Basic | 152.63% | 386.94% | -15.37% | -3,328.40% | -109.29% |
| Normalized Basic EPS | 207.30% | 148.62% | 48.45% | -2.20% | 61.06% |
| EPS Diluted | 151.43% | 440.50% | -15.38% | -2,758.67% | -109.59% |
| Normalized Diluted EPS | 205.71% | 147.08% | 47.22% | -2.20% | 60.82% |
| Average Basic Shares Outstanding | 0.58% | 0.58% | 0.53% | 0.51% | 0.51% |
| Average Diluted Shares Outstanding | 1.95% | 1.16% | 1.38% | 0.51% | -0.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |